Does duloxetine cause migraines? (+5 factors)

In this article, we will discuss whether duloxetine causes migraines. We will also discuss the factors that may increase the risk of migraines during treatment with duloxetine, as well as the management of migraines while taking duloxetine.

Does duloxetine cause migraines? 

No, duloxetine does not cause migraines. Instead, research studies have demonstrated effectiveness of duloxetine in managing and preventing migraines. However, duloxetine can cause headaches, which is a commonly reported side effect of this medication (2).

Duloxetine is an antidepressant medication that is most commonly used in the management of various health conditions such as depression, anxiety and fibromyalgia. Its therapeutic benefits are associated with its interference with the levels of serotonin and norepinephrine in the brain. These neurotransmitters are responsible for the elevation of mood and reduction of other symptoms of depression and anxiety (1).

The incidence of serious side effects of this medication is low and it is generally considered as a well tolerated medication. However, individual responses to medications amy vary and it may cause serious side effects in susceptible individuals.

What does research suggest?

Research findings do not support a direct link between the use of duloxetine and the onset of migraines. However, frequent reports of headaches have been observed in individuals undergoing duloxetine treatment.

In a research study addressing the management of depression symptoms, duloxetine demonstrated effectiveness; however, approximately 10% of participants reported experiencing common side effects, including headaches (2).

Additionally, studies have explored and affirmed the efficacy of duloxetine in both preventing and managing migraines, although it is not recognized as a direct cause of migraines (3).

What factors can increase the risk of migraines while taking duloxetine?

Migraine is not a common side effect associated with duloxetine. However, there are some general factors that can contribute to migraines in some individuals. While not everyone with these factors will necessarily develop migraines, they may contribute to an increased susceptibility. These factors may include:

Use of medications: While many medications are generally safe and do not cause migraines, certain medications have been reported by some individuals to induce migraine headaches. These medications may include nitrates, beta-blockers, caffeine-containing analgesics, and some antidepressant medications such as amitriptyline. 

Unhealthy lifestyle: An unhealthy lifestyle, characterized by disrupted sleep patterns, unhealthy diet, less water intake reduced physical activity, stress, and inconsistent routines, significantly increases the risk of migraines.

Sleep disturbances: Lack of sleep or irregular sleep patterns, including both insufficient and excessive sleep, can increase the likelihood of experiencing migraines.

Use of alcohol: The risk of experiencing migraines increases with the use of alcohol because alcohol increases the levels of histamine in the body that causes migraines. 

Underlying health conditions: Migraines can be associated with certain medical conditions or factors, and individuals with these conditions may be more prone to experiencing migraines. Examples of these medical conditions may include, fibromyalgia, cervical spine disorder, and insomnia.

How to treat migraines while taking duloxetine?

The treatment of migraines typically involves a combination of pharmacological and non-pharmacological interventions. However, it is important to note that the management of migraines varies from person to person, and a healthcare professional should be consulted to develop an individualized treatment plan.

Pharmacological treatment of migraines may involve the use of the following medications (4):

  • Analgesics including NSAIDs (aspirin, acetaminophen) and other over-the-counter medications used for the management of head pain and discomfort during migraine.
  • Antiemetics (metoclopramide) for the treatment of nausea and vomiting associated with migraines.
  • Triptans and ergotamines constrict the blood vessels and reduce pain sensations in migraines. These medications are also involved in the elevation of serotonin levels in the brain.

As with any medication, it is crucial for individuals to consult with their healthcare provider to determine the most appropriate treatment plan for their specific needs.

What are the non-pharmacological interventions for migraine?

Non-pharmacological approaches for managing migraines primarily involve lifestyle changes and behavioral interventions (5). Although these strategies may not completely eliminate migraines, they can significantly contribute to reducing the episodes of migraine.

A consistent sleep routine with regular sleep and wake times, avoiding certain foods that contain tyramine, caffeine, or artificial sweeteners, and drinking an adequate amount of water may contribute to migraine management (5).

Furthermore, incorporating regular exercise, meditation, and head massages into one’s routine may also be effective in managing migraine attacks. Engaging in consistent physical activity, such as swimming, or yoga, can help reduce stress and tension, both of which are common risk factors for migraines.

In my opinion, the effectiveness of non-pharmacological approaches can vary from person to person. Consulting with a healthcare professional is advisable to develop an individualized migraine management plan. Additionally, individuals with migraines should seek medical advice for any new or worsening symptoms.

Was this helpful?

Thanks for your feedback!

References

1.-

Dhaliwal JS, Spurling BC, Molla M. Duloxetine. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31747213. https://pubmed.ncbi.nlm.nih.gov/31747213/

2.-

Goldstein DJ. Duloxetine in the treatment of major depressive disorder. Neuropsychiatr Dis Treat. 2007 Apr;3(2):193-209. doi: 10.2147/nedt.2007.3.2.193. PMID: 19300553; PMCID: PMC2654630. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654630/

3.-

Artemenko AR, Kurenkov AL, Nikitin SS, Filatova EG. [Duloxetine in the treatment of chronic migraine]. Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(1):49-54. Russian. PMID: 20436437. https://pubmed.ncbi.nlm.nih.gov/20436437/

4.-

Ferrari MD, Goadsby PJ, Burstein R, Kurth T, Ayata C, Charles A, Ashina M, van den Maagdenberg AMJM, Dodick DW. Migraine. Nat Rev Dis Primers. 2022 Jan 13;8(1):2. doi: 10.1038/s41572-021-00328-4. PMID: 35027572.

5.-

Haghdoost F, Togha M. Migraine management: Non-pharmacological points for patients and health care professionals. Open Med (Wars). 2022 Nov 23;17(1):1869-1882. doi: 10.1515/med-2022-0598. PMID: 36475060; PMCID: PMC9691984. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691984/

Find a supportive therapist who can help with Depression.

Discover the convenience of BetterHelp, an online therapy platform connecting you with licensed and accredited therapists specialized in addressing issues such as depression, anxiety, relationships, and more. Complete the assessment and find your ideal therapist within just 48 hours.

 

AskYourPharm is user-supported. We may earn a commission if you sign up for BetterHelp’s services after clicking through from this site